WIGRETTES Drug Patent Profile
When do Wigrettes patents expire, and when can generic versions of Wigrettes launch?
Wigrettes is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in WIGRETTES is ergotamine tartrate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for WIGRETTES?
- What are the global sales for WIGRETTES?
- What is Average Wholesale Price for WIGRETTES?
Summary for WIGRETTES
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 53 |
| DailyMed Link: | WIGRETTES at DailyMed |
US Patents and Regulatory Information for WIGRETTES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | WIGRETTES | ergotamine tartrate | TABLET;SUBLINGUAL | 086750-001 | Jul 29, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
